Stock 688193 SHANGHAI RENDU BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Rendu Biotechnology Co., Ltd.

Equities

688193

CNE1000059K5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
33.41 CNY -2.08% Intraday chart for Shanghai Rendu Biotechnology Co., Ltd. +5.90% -25.95%
04-29 Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-02 Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 1,869 1,805
Enterprise Value (EV) 1 1,049 1,152
P/E ratio 76.6 x 215 x
Yield 0.27% -
Capitalization / Revenue 6.15 x 11 x
EV / Revenue 3.45 x 7.01 x
EV / EBITDA 60.2 x 246 x
EV / FCF -35,290,871 x -9,439,390 x
FCF Yield -0% -0%
Price to Book 1.94 x 1.87 x
Nbr of stocks (in thousands) 40,000 40,000
Reference price 2 46.72 45.12
Announcement Date 23-04-25 24-04-19
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 69.34 99.17 249.9 292.3 303.8 164.4
EBITDA 1 -29.51 2.522 67.73 70.93 17.42 4.685
EBIT 1 -32.97 -1.64 62.04 62.58 5.018 -8.322
Operating Margin -47.55% -1.65% 24.83% 21.41% 1.65% -5.06%
Earnings before Tax (EBT) 1 -33.64 4.01 70.24 72.44 26.68 4.763
Net income 1 -32.05 3.739 61.38 64.62 23.33 8.259
Net margin -46.22% 3.77% 24.56% 22.11% 7.68% 5.02%
EPS 2 -1.140 0.1252 2.040 2.130 0.6100 0.2100
Free Cash Flow - -45.53 45.44 -3.449 -29.74 -122
FCF margin - -45.91% 18.18% -1.18% -9.79% -74.23%
FCF Conversion (EBITDA) - - 67.09% - - -
FCF Conversion (Net income) - - 74.04% - - -
Dividend per Share - - - - 0.1250 -
Announcement Date 21-06-17 21-06-17 21-06-17 22-03-28 23-04-25 24-04-19
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 91.3 74.3 168 194 819 653
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - -45.5 45.4 -3.45 -29.7 -122
ROE (net income / shareholders' equity) - 2.55% 33.6% 25.7% 3.74% 0.86%
ROA (Net income/ Total Assets) - -0.58% 15.6% 11.3% 0.43% -0.49%
Assets 1 - -648.5 394 569.5 5,458 -1,702
Book Value Per Share 2 5.070 5.050 7.170 9.590 24.00 24.10
Cash Flow per Share 2 0.6900 1.410 5.730 6.600 7.470 15.20
Capex 1 7.1 54.8 15.5 26.5 21.2 20.4
Capex / Sales 10.24% 55.29% 6.22% 9.06% 6.98% 12.4%
Announcement Date 21-06-17 21-06-17 21-06-17 22-03-28 23-04-25 24-04-19
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. Stock Shanghai Rendu Biotechnology Co., Ltd.
-25.95% 185M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.84% 182B
MEDTRONIC PLC Stock Medtronic plc
+0.56% 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.35% 68.11B
DEXCOM, INC. Stock DexCom, Inc.
+2.39% 50.53B
CENCORA, INC. Stock Cencora, Inc.
+9.36% 44.8B
HOYA CORPORATION Stock Hoya Corporation
+2.70% 40.7B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.43% 26.53B
TERUMO CORPORATION Stock Terumo Corporation
+13.67% 25.02B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-0.32% 24.96B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 688193 Stock
  4. Financials Shanghai Rendu Biotechnology Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW